Cervical Occlusion Double-level Stitch Application (COSA)
Primary Purpose
Cervical Incompetence
Status
Recruiting
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Double-level cervical cerclage
Single-level cervical cerclage
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Incompetence focused on measuring pregnancy, premature birth, cervix, pregnancy complication
Eligibility Criteria
Inclusion Criteria:
- singleton pregnancy,
- gestational age 16+0 to 23+6 weeks,
- live fetus,
- cervical incompetence with fetal membranes visible through external os before 24+0 weeks of gestation.
Exclusion Criteria:
- preterm rupture of membranes,
- vaginal bleeding,
- regular uterine contractions,
- maternal fever,
- diagnosed fetal genetic disorders,
- diagnosed major fetal anomalies,
- multiple pregnancy,
- congenital uterine anomalies,
- fetal demise,
- maternal leukocyte count >20 million/microliter,
- maternal serum C-reactive protein concentration > 20 mg/L
Sites / Locations
- Department of Obstetrics, Women's Diseases and Oncological Gynecology, Nicolaus Copernicus UniversityRecruiting
- 1st Department of Obstetrics and Gynecology, Center of Postagraduate Medical EducationRecruiting
- Department of Obstetrics, Perinatology and Neonatology, Center of Postagraduate Medical EducationRecruiting
- 1st Department of Obstetrics and Gynecology, Medical University of WarsawRecruiting
- Department of Obstetrics and Gynecology, Oncological Gynecology and Gynecological Endocrinology, Medical University of GdanskRecruiting
- Pomeranian Medical University SzczecinRecruiting
- Polish Mother's Memorial Hospital - Research InstituteRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Double-level cerclage
Single-level cerclage
Arm Description
double-level cervical cerclage placement with one suture above the other approximately 1 cm higher. Suture will be placed analogous to McDonald technique
single-level cervical cerclage of McDonald technique
Outcomes
Primary Outcome Measures
deliveries below 34+0 weeks of gestation
number and rate of deliveries below 34+0 weeks of gestation
Secondary Outcome Measures
gestational age at delivery
duration of pregnancy untill delivery in weeks and days
time from cerclage administration to delivery
time from cerclage administration to delivery in days
fetal demise
number and rate of pregnancies complicated by fetal demise
neonatal outcomes
number and rate of: congenital infections, respiratory morbidity, hospitalizations in the Neonatal Intensive Care Unit, early neurodevelopmental morbidity, gastrointestinal morbidity, retinopathy of prematurity, newborn's death before the discharge home
birth weight
neonatal weight at delivery in grams
5th minute Apgar score
neonatal general condition at 5th minute after delivery according to the Apgar Scale
maternal outcomes
maternal mortality, miscarriage, intrauterine infection, prelabour rupture of membranes, o cervical laceration
Full Information
NCT ID
NCT05268640
First Posted
January 19, 2022
Last Updated
May 22, 2023
Sponsor
Centre of Postgraduate Medical Education
Collaborators
Pomeranian Medical University Szczecin, Polish Mother Memorial Hospital Research Institute, Medical University of Warsaw, Medical University of Gdansk, Nicolaus Copernicus University
1. Study Identification
Unique Protocol Identification Number
NCT05268640
Brief Title
Cervical Occlusion Double-level Stitch Application
Acronym
COSA
Official Title
Comparison of the Efficacy of Emergency Double-level and Single Cervical Cerclage in Cervical Insufficiency in the Second Trimester of Pregnancy - Multicenter Prospective Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 11, 2022 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
February 28, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre of Postgraduate Medical Education
Collaborators
Pomeranian Medical University Szczecin, Polish Mother Memorial Hospital Research Institute, Medical University of Warsaw, Medical University of Gdansk, Nicolaus Copernicus University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Cervical insufficiency is defined as painless dilatation of the cervix during the second trimester of pregnancy. As a result of shortening and opening of the cervix, despite the lack of uterine contractions, the fetal membranes invade into the cervical canal and then into the vagina, which results in premature rupture of the membranes and miscarriage or preterm delivery. Cervical insufficiency occurs in approximately 1% of the women. The aim of the study is to evaluate the effectiveness of placing a double-level cervical cerclage in the treatment of advanced cervical insufficiency. The hypothesis assumes that the insertion of a double-level suture is associated with a reduction in the rate of deliveries < 34 weeks of gestation in comparison to single-level suture. The study will include women with fetal membranes visible through open external os of the cervix between 16+0 and 23+6 weeks. They will be randomized to two arms - McDonald's single cervical cerclage or two-level cerclage.
Detailed Description
This is an open-label, multicentre, prospective, randomised controlled trial (RCT). Women will be randomized to the single-level cerclage arm or the double-level cerclage. Each patient will have a vaginal swab for aerobic and anaerobic bacteria and fungi culture, as well as for mycoplasmas, chlamydia and ureaplasma performed. Each patient will be treated with progesterone (vaginally 2 x 100 mg per day) and empirical antibiotic therapy (ceftriaxone 2.0 g iv + clarithromycin 2 x 500 mg po + metronidazole 3 x 500 mg iv for 7 days). If specific pathogens will be detected, the antibiotic therapy will be modified according to the antibiogram. If the diagnosis of cervical insufficiency will be made >23 weeks of gestation a single course of corticosteroid therapy will be administered (betamethasone 2 x 12 mg im) if the rsik of delivery within 7 days will be assessed as high. Indomethacin will also be administered for 48 hours (starting the day of cerclage administration, indomethacin 2 x 75 mg po for 48 hours). In the single-level cerclage arm McDonald suture will be administered. In the double-level cerclage arm two separate sutures analogous to McDonald technique will be placed, one approximately 1 cm higher above the other. Patients will be followed up until miscarriage or delivery and will receive standard perinatal care. Gestational age at delivery, the occurrence of cerclage complications and neonatal outcomes will be analyzed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Incompetence
Keywords
pregnancy, premature birth, cervix, pregnancy complication
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
78 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Double-level cerclage
Arm Type
Experimental
Arm Description
double-level cervical cerclage placement with one suture above the other approximately 1 cm higher. Suture will be placed analogous to McDonald technique
Arm Title
Single-level cerclage
Arm Type
Active Comparator
Arm Description
single-level cervical cerclage of McDonald technique
Intervention Type
Procedure
Intervention Name(s)
Double-level cervical cerclage
Intervention Description
two cervical sutures + regimen of antibiotics + indomethacin + progesterone
Intervention Type
Procedure
Intervention Name(s)
Single-level cervical cerclage
Intervention Description
single cervical suture + regimen of antibiotics + indomethacin + progesterone
Primary Outcome Measure Information:
Title
deliveries below 34+0 weeks of gestation
Description
number and rate of deliveries below 34+0 weeks of gestation
Time Frame
observation after intervention for 26 weeks of until birth
Secondary Outcome Measure Information:
Title
gestational age at delivery
Description
duration of pregnancy untill delivery in weeks and days
Time Frame
observation after intervention for 26 weeks of until birth
Title
time from cerclage administration to delivery
Description
time from cerclage administration to delivery in days
Time Frame
observation after intervention for 26 weeks of until birth
Title
fetal demise
Description
number and rate of pregnancies complicated by fetal demise
Time Frame
observation after intervention for 26 weeks of until birth
Title
neonatal outcomes
Description
number and rate of: congenital infections, respiratory morbidity, hospitalizations in the Neonatal Intensive Care Unit, early neurodevelopmental morbidity, gastrointestinal morbidity, retinopathy of prematurity, newborn's death before the discharge home
Time Frame
observation after intervention for 26 weeks of until birth
Title
birth weight
Description
neonatal weight at delivery in grams
Time Frame
observation after intervention for 26 weeks of until birth
Title
5th minute Apgar score
Description
neonatal general condition at 5th minute after delivery according to the Apgar Scale
Time Frame
observation after intervention for 26 weeks of until birth
Title
maternal outcomes
Description
maternal mortality, miscarriage, intrauterine infection, prelabour rupture of membranes, o cervical laceration
Time Frame
observation after intervention for 26 weeks of until birth
Other Pre-specified Outcome Measures:
Title
cerclage procedure complications occurring within 48 hours after cerclage placement
Description
excessive vaginal bleeding, intrauterine infection, prelabour rupture of membranes
Time Frame
observation after intervention for 48 hours
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Female - pregnant women
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
singleton pregnancy,
gestational age 16+0 to 23+6 weeks,
live fetus,
cervical incompetence with fetal membranes visible through external os before 24+0 weeks of gestation,
informed written consent.
Exclusion Criteria - any of the following occuring before the administration of the cerclage:
preterm premature rupture of membranes,
vaginal bleeding,
active regular uterine contractions,
fetal demise,
fever,
intrauterine infection (diagnosed in case of maternal body temperature ≥ 38°C with no alternative cause identified and at least 2 symptoms among the following appear: fetal tachycardia > 160 bpm for 10 minutes or longer, uterine pain, purulent vaginal discharge, white blood cell count > 15 G/L in the absence of corticosteroid treatment or increased plasma C-reactive protein > 10 mg/L),
known genetic defects of the fetus,
known lethal fetal malformations,
congenital uterine defects,
multiple pregnancy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Katarzyna Kosinska-Kaczynska, Prof.
Phone
22 5690274
Ext
+48
Email
katarzyna.kosinska-kaczynska@cmkp.edu.pl
First Name & Middle Initial & Last Name or Official Title & Degree
Beata Rebizant, MD PhD
Phone
22 5690274
Ext
+48
Email
beata.rebizant@bielanski.med.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katarzyna Kosinska Kaczynska, Prof.
Organizational Affiliation
Center of Postgraduate Medical Education
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Anna Kajdy, MD PhD
Organizational Affiliation
Center of Postgraduate Medical Education
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sebastian Kwiatkowski, Prof.
Organizational Affiliation
Pomeranian Medical University Szczecin
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mariusz Grzesiak, Prof.
Organizational Affiliation
Polish Mother's Memorial Hospital - Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Obstetrics, Women's Diseases and Oncological Gynecology, Nicolaus Copernicus University
City
Bydgoszcz
State/Province
Kujawsko-pomorskie
ZIP/Postal Code
85-168
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Szymon Bednarek, MD PhD
Email
prenatalium@gmail.com
Facility Name
1st Department of Obstetrics and Gynecology, Center of Postagraduate Medical Education
City
Warsaw
State/Province
Mazowieckie
ZIP/Postal Code
01-004
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Kajdy, MD PhD
Phone
22 2559801
Ext
+48
Email
anna.kajdy@cmkp.edu.pl
Facility Name
Department of Obstetrics, Perinatology and Neonatology, Center of Postagraduate Medical Education
City
Warsaw
State/Province
Mazowieckie
ZIP/Postal Code
01-809
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katarzyna Kosinska-Kaczynska, Prof.
Phone
22 5690274
Ext
+48
Email
katarzyna.kosinska-kaczynska@cmkp.edu.pl
Facility Name
1st Department of Obstetrics and Gynecology, Medical University of Warsaw
City
Warsaw
State/Province
Mazowieckie
ZIP/Postal Code
02-015
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Monika Szpotańska-Sikorska, Prof.
Email
monika.szpotanska1@gmail.com
Facility Name
Department of Obstetrics and Gynecology, Oncological Gynecology and Gynecological Endocrinology, Medical University of Gdansk
City
Gdańsk
State/Province
Pomorskie
ZIP/Postal Code
80-952
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katarzyna Stefańska, MD PhD
Email
kciach@icloud.com
Facility Name
Pomeranian Medical University Szczecin
City
Szczecin
State/Province
Zachodniopomorskie
ZIP/Postal Code
70-111
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sebastian Kwiatkowski, Prof.
Phone
91 4661350
Ext
+48
Email
kwiatkowskiseba@gmail.com
Facility Name
Polish Mother's Memorial Hospital - Research Institute
City
Łódź
State/Province
Łodzkie
ZIP/Postal Code
93-338
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mariusz Grzesiak, Prof.
Phone
42 2711000
Ext
+48
Email
mariusz.grzesiak@iczmp.edu.pl
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
IPD share with other researchers will include all IPD that underlie results in a publication
IPD Sharing Time Frame
Data will become available after completing of recruitment and will be available for 12 months
IPD Sharing Access Criteria
Data will be available od request sent to the principal researchers. All requests for information will be reviewed by the Study Officials.
Citations:
PubMed Identifier
16449104
Citation
Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Management of cervical insufficiency and bulging fetal membranes. Obstet Gynecol. 2006 Feb;107(2 Pt 1):221-6. doi: 10.1097/01.AOG.0000187896.04535.e6.
Results Reference
result
PubMed Identifier
18243484
Citation
Stupin JH, David M, Siedentopf JP, Dudenhausen JW. Emergency cerclage versus bed rest for amniotic sac prolapse before 27 gestational weeks. A retrospective, comparative study of 161 women. Eur J Obstet Gynecol Reprod Biol. 2008 Jul;139(1):32-7. doi: 10.1016/j.ejogrb.2007.11.009. Epub 2008 Feb 20.
Results Reference
result
PubMed Identifier
14586323
Citation
Althuisius SM, Dekker GA, Hummel P, van Geijn HP; Cervical incompetence prevention randomized cerclage trial. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol. 2003 Oct;189(4):907-10. doi: 10.1067/s0002-9378(03)00718-x.
Results Reference
result
PubMed Identifier
30928565
Citation
Oh KJ, Romero R, Park JY, Lee J, Conde-Agudelo A, Hong JS, Yoon BH. Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency. Am J Obstet Gynecol. 2019 Aug;221(2):140.e1-140.e18. doi: 10.1016/j.ajog.2019.03.017. Epub 2019 Mar 28.
Results Reference
result
PubMed Identifier
24807330
Citation
Miller ES, Grobman WA, Fonseca L, Robinson BK. Indomethacin and antibiotics in examination-indicated cerclage: a randomized controlled trial. Obstet Gynecol. 2014 Jun;123(6):1311-1316. doi: 10.1097/AOG.0000000000000228.
Results Reference
result
PubMed Identifier
26974218
Citation
Wood SL, Owen J. Cerclage: Shirodkar, McDonald, and Modifications. Clin Obstet Gynecol. 2016 Jun;59(2):302-10. doi: 10.1097/GRF.0000000000000190.
Results Reference
result
PubMed Identifier
22399222
Citation
Park JM, Tuuli MG, Wong M, Carbone JF, Ismail M, Macones GA, Odibo AO. Cervical cerclage: one stitch or two? Am J Perinatol. 2012 Jun;29(6):477-81. doi: 10.1055/s-0032-1304831. Epub 2012 Mar 7.
Results Reference
result
PubMed Identifier
23201330
Citation
Giraldo-Isaza MA, Fried GP, Hegarty SE, Suescum-Diaz MA, Cohen AW, Berghella V. Comparison of 2 stitches vs 1 stitch for transvaginal cervical cerclage for preterm birth prevention. Am J Obstet Gynecol. 2013 Mar;208(3):209.e1-9. doi: 10.1016/j.ajog.2012.11.039. Epub 2012 Nov 28.
Results Reference
result
PubMed Identifier
18177834
Citation
Woensdregt K, Norwitz ER, Cackovic M, Paidas MJ, Illuzzi JL. Effect of 2 stitches vs 1 stitch on the prevention of preterm birth in women with singleton pregnancies who undergo cervical cerclage. Am J Obstet Gynecol. 2008 Apr;198(4):396.e1-7. doi: 10.1016/j.ajog.2007.10.782. Epub 2008 Feb 21.
Results Reference
result
Learn more about this trial
Cervical Occlusion Double-level Stitch Application
We'll reach out to this number within 24 hrs